Eli Lilly and Co
NYSE:LLY

Watchlist Manager

Eli Lilly and Co

NYSE:LLY

Watchlist

Dividends

Price: 786.23 USD -3.15% Market Closed

Market Cap: 747.3B USD

Have any thoughts about
Eli Lilly and Co?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Johnson & Johnson NYSE:JNJ	Pharmaceuticals
US	Estee Lauder Companies Inc NYSE:EL	Consumer products
US	Exxon Mobil Corp NYSE:XOM	Energy
US	Church & Dwight Co Inc NYSE:CHD	Consumer products
US	Pfizer Inc NYSE:PFE	Pharmaceuticals
US	American Express Co NYSE:AXP	Financial Services
US	Nike Inc NYSE:NKE	Textiles, Apparel & Luxury Goods
US	Visa Inc NYSE:V	Technology
CN	Alibaba Group Holding Ltd NYSE:BABA	Retail
US	3M Co NYSE:MMM	Industrial Conglomerates
US	JPMorgan Chase & Co NYSE:JPM	Banking
US	Coca-Cola Co NYSE:KO	Beverages
US	Target Corp NYSE:TGT	Retail
US	Walt Disney Co NYSE:DIS	Media
US	Mueller Industries Inc NYSE:MLI	Machinery
US	PayPal Holdings Inc NASDAQ:PYPL	Technology

Add Price Alert

Price Target:

Last Price: 786.23 USD

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

LLY Alert

Eli Lilly and Co

786.23

-25.58 (-3.15%)

52 Week Range	570.21 960.02
Price Target

We'll email you a reminder when the closing price reaches USD.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Johnson & Johnson NYSE:JNJ	US
	Estee Lauder Companies Inc NYSE:EL	US
	Exxon Mobil Corp NYSE:XOM	US
	Church & Dwight Co Inc NYSE:CHD	US
	Pfizer Inc NYSE:PFE	US
	American Express Co NYSE:AXP	US
	Nike Inc NYSE:NKE	US
	Visa Inc NYSE:V	US
	Alibaba Group Holding Ltd NYSE:BABA	CN
	3M Co NYSE:MMM	US
	JPMorgan Chase & Co NYSE:JPM	US
	Coca-Cola Co NYSE:KO	US
	Target Corp NYSE:TGT	US
	Walt Disney Co NYSE:DIS	US
	Mueller Industries Inc NYSE:MLI	US
	PayPal Holdings Inc NASDAQ:PYPL	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Eli Lilly and Co

What unique competitive advantages
does Eli Lilly and Co hold over its rivals?

What risks and challenges
does Eli Lilly and Co face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of Eli Lilly and Co.

What unique competitive advantages
does Eli Lilly and Co hold over its rivals?

What risks and challenges
does Eli Lilly and Co face in the near future?

Has there been any significant insider trading activity
in Eli Lilly and Co recently?

Summarize the latest earnings call
of Eli Lilly and Co.

What significant events have occurred
in Eli Lilly and Co over the past months?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Eli Lilly and Co.

Provide P/S
for Eli Lilly and Co.

Provide P/E
for Eli Lilly and Co.

Provide P/OCF
for Eli Lilly and Co.

Provide P/FCFE
for Eli Lilly and Co.

Provide P/B
for Eli Lilly and Co.

Provide EV/S
for Eli Lilly and Co.

Provide EV/GP
for Eli Lilly and Co.

Provide EV/EBITDA
for Eli Lilly and Co.

Provide EV/EBIT
for Eli Lilly and Co.

Provide EV/OCF
for Eli Lilly and Co.

Provide EV/FCFF
for Eli Lilly and Co.

Provide EV/IC
for Eli Lilly and Co.

Show me price targets
for Eli Lilly and Co made by professional analysts.

What are the Revenue projections
for Eli Lilly and Co?

How accurate were the past Revenue estimates
for Eli Lilly and Co?

What are the Net Income projections
for Eli Lilly and Co?

How accurate were the past Net Income estimates
for Eli Lilly and Co?

What are the EPS projections
for Eli Lilly and Co?

How accurate were the past EPS estimates
for Eli Lilly and Co?

What are the EBIT projections
for Eli Lilly and Co?

How accurate were the past EBIT estimates
for Eli Lilly and Co?

Compare the revenue forecasts
for Eli Lilly and Co with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Eli Lilly and Co and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Eli Lilly and Co against its competitors.

Analyze the profit margins
(gross, operating, and net) of Eli Lilly and Co compared to its peers.

Compare the P/E ratios
of Eli Lilly and Co against its peers.

Discuss the investment returns and shareholder value creation
comparing Eli Lilly and Co with its peers.

Analyze the financial leverage
of Eli Lilly and Co compared to its main competitors.

Show all profitability ratios
for Eli Lilly and Co.

Provide ROE
for Eli Lilly and Co.

Provide ROA
for Eli Lilly and Co.

Provide ROIC
for Eli Lilly and Co.

Provide ROCE
for Eli Lilly and Co.

Provide Gross Margin
for Eli Lilly and Co.

Provide Operating Margin
for Eli Lilly and Co.

Provide Net Margin
for Eli Lilly and Co.

Provide FCF Margin
for Eli Lilly and Co.

Show all solvency ratios
for Eli Lilly and Co.

Provide D/E Ratio
for Eli Lilly and Co.

Provide D/A Ratio
for Eli Lilly and Co.

Provide Interest Coverage Ratio
for Eli Lilly and Co.

Provide Altman Z-Score Ratio
for Eli Lilly and Co.

Provide Quick Ratio
for Eli Lilly and Co.

Provide Current Ratio
for Eli Lilly and Co.

Provide Cash Ratio
for Eli Lilly and Co.

What is the historical Revenue growth
over the last 5 years for Eli Lilly and Co?

What is the historical Net Income growth
over the last 5 years for Eli Lilly and Co?

What is the current Free Cash Flow
of Eli Lilly and Co?

Discuss the annual earnings per share (EPS)
trend over the past five years for Eli Lilly and Co.

LLY

Income Statement

Income from Continuing Operations

Eli Lilly and Co
Income from Continuing Operations

Last Value

3-Years 3-Y CAGR

5-Years 5-Y CAGR

10-Years 10-Y CAGR

Quarterly

Annual

TTM

Adjust for Inflation

Eli Lilly and Co
Income from Continuing Operations Peer Comparison

Comparables:

JNJ

BMY

PFE

MRK

ZTS

Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors

	Income from Continuing Operations	CAGR 3Y	CAGR 5Y	CAGR 10Y
Eli Lilly and Co NYSE:LLY	Income from Continuing Operations $8.4B	CAGR 3-Years 12%	CAGR 5-Years 14%	CAGR 10-Years 12%
Johnson & Johnson NYSE:JNJ	Income from Continuing Operations $14.8B	CAGR 3-Years -6%	CAGR 5-Years 1%	CAGR 10-Years -2%
Bristol-Myers Squibb Co NYSE:BMY	Income from Continuing Operations -$7.2B	CAGR 3-Years -10%	CAGR 5-Years N/A	CAGR 10-Years N/A
Pfizer Inc NYSE:PFE	Income from Continuing Operations $4.3B	CAGR 3-Years -40%	CAGR 5-Years 4%	CAGR 10-Years -9%
Merck & Co Inc NYSE:MRK	Income from Continuing Operations $12.2B	CAGR 3-Years 27%	CAGR 5-Years 5%	CAGR 10-Years 8%
Zoetis Inc NYSE:ZTS	Income from Continuing Operations $2.4B	CAGR 3-Years 7%	CAGR 5-Years 11%	CAGR 10-Years 16%

What is Eli Lilly and Co's Income from Continuing Operations?

Income from Continuing Operations
8.4B USD

Based on the financial report for Sep 30, 2024, Eli Lilly and Co's Income from Continuing Operations amounts to 8.4B USD.

What is Eli Lilly and Co's Income from Continuing Operations growth rate?

Income from Continuing Operations CAGR 10Y
12%

Over the last year, the Income from Continuing Operations growth was 68%. The average annual Income from Continuing Operations growth rates for Eli Lilly and Co have been 12% over the past three years , 14% over the past five years , and 12% over the past ten years .

Eli Lilly and Co
NYSE:LLY

Eli Lilly and Co
Income from Continuing Operations

Eli Lilly and Co
Income from Continuing Operations Peer Comparison

Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors

See Also

What is Eli Lilly and Co's Income from Continuing Operations?

Income from Continuing Operations
8.4B USD

What is Eli Lilly and Co's Income from Continuing Operations growth rate?

Income from Continuing Operations CAGR 10Y
12%

Company

Help

Tools

Stocks

Eli Lilly and Co NYSE:LLY

Eli Lilly and Co Income from Continuing Operations

Eli Lilly and Co Income from Continuing Operations Peer Comparison

Competitive Income from Continuing Operations Analysis Latest Figures & CAGR of Competitors

See Also

What is Eli Lilly and Co's Income from Continuing Operations? Income from Continuing Operations 8.4B USD

What is Eli Lilly and Co's Income from Continuing Operations growth rate? Income from Continuing Operations CAGR 10Y 12%

Company

Help

Tools

Stocks

Eli Lilly and Co
NYSE:LLY

Eli Lilly and Co
Income from Continuing Operations

Eli Lilly and Co
Income from Continuing Operations Peer Comparison

Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors

What is Eli Lilly and Co's Income from Continuing Operations?

Income from Continuing Operations
8.4B USD

What is Eli Lilly and Co's Income from Continuing Operations growth rate?

Income from Continuing Operations CAGR 10Y
12%